Anzeige
Mehr »
Login
Freitag, 24.01.2025 Börsentäglich über 12.000 News von 683 internationalen Medien
Hinter dem nuklearen Ansturm im Silicon Valley: Eine strategische Chance entsteht
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
ACCESS Newswire
325 Leser
Artikel bewerten:
(2)

EPA Recommends My Green Lab Certification and ACT Ecolabel, Setting the Standard for Sustainable Science

Finanznachrichten News

This recommendation reinforces the integrity and transparency of My Green Lab's standard development process, and the high-quality and rigor of its certification and ecolabel programs.

SAN DIEGO, CA / ACCESSWIRE / December 10, 2024 / My Green Lab, the global nonprofit organization dedicated to improving the sustainability of laboratory research, is proud to announce the recommendation of both My Green Lab Certification and the ACT Ecolabel Program into the Environmental Protection Agency's (EPA) Environmentally Preferable Purchasing (EPP) Program. This mark of distinction from EPA highlights the credibility of My Green Lab's programs and their alignment with international best practices.

EPA's Recommendations of Specifications, Standards, and Ecolabels help federal purchasers identify and procure environmentally preferable products and services. Federal purchasers are directed in Executive Order 14057 on Catalyzing American Clean Energy Industries and Jobs through Federal Sustainability, the Federal Sustainability Plan, and subpart 23.1 of the Federal Acquisition Regulation to procure products and services meeting the Recommendations to meet net-zero emissions and other procurement goals. Alignment with federal sustainability goals demonstrates that My Green Lab Certification and the ACT Ecolabel Program meet the highest international standards, driving meaningful progress toward reducing the environmental impact of scientific research.

"EPA's recommendation is a powerful validation of our work at My Green Lab," said James Connelly, CEO of My Green Lab. "This distinction affirms the integrity of our programs and their critical role in reducing the environmental impact of laboratories and laboratory products. With EPA's support, we are one step closer to making green labs the global standard."

This independent review by one of the world's most recognized environmental authorities affirms that both My Green Lab's standard development process and its criteria adhere to best practices for environmental certifications. EPA's recommendation further establishes My Green Lab Certification as the world's most trusted standard for implementing sustainability best practices in laboratories, while the ACT Ecolabel serves as a critical tool to help procurement teams and scientists make informed, sustainable choices that align with federal sustainability goals.

About My Green Lab

My Green Lab® is a nonprofit environmental organization with a mission to build a global culture of sustainability in science. The organization is the world leader in developing internationally recognized sustainability standards for laboratories and laboratory products-bringing sustainability to the community responsible for the world's life-changing medical and technical innovations. Laboratories are some of the most resource-intensive spaces in any industry, but they don't have to be. By introducing a new perspective and proven best practices within a carefully crafted framework, My Green Lab has inspired tens of thousands of scientists and lab professionals to make positive changes in their labs by reducing the environmental impact of their work.

My Green Lab Certification

The world's most trusted green lab certification, guiding scientists and lab teams toward actionable sustainability practices. Supported by third-party verification from Impact Laboratories, My Green Lab Certification has engaged 3,450 labs in 50 countries reaching over 41,000 scientists.

My Green Lab ACT Ecolabel

The ACT Ecolabel provides transparent, third-party verified data about the environmental impact of laboratory products. By offering clear information on product sustainability, the ACT Ecolabel empowers procurement teams and scientists to make informed, sustainable choices. The ACT Ecolabel database includes 3,400 labels from 40 manufacturers.

For media requests, contact Christina Creager at christina.creager@mygreenlab.org.

For more information about My Green Lab, visit mygreenlab.org.

View additional multimedia and more ESG storytelling from My Green Lab on 3blmedia.com.

Contact Info:
Spokesperson: My Green Lab
Website: https://www.3blmedia.com/profiles/my-green-lab
Email: info@3blmedia.com

SOURCE: My Green Lab



View the original press release on accesswire.com

© 2024 ACCESS Newswire
Gewinner im Megamarkt
Biotechnologie ist eine der bedeutendsten Zukunftstechnologien unserer Zeit. Zahlreiche Biotechnologie- und Pharmakonzerne haben sich unter anderem dem Kampf gegen Tumorerkrankungen verschrieben. Der weltweite Markt für Krebsmedikamente verzeichnet ein stetiges Wachstum. Für das Jahr 2025 wird ein Umsatz von etwa 190,3 Milliarden Euro prognostiziert, mit einer erwarteten jährlichen Wachstumsrate von 6,42% bis 2029, was zu einem geschätzten Marktvolumen von 244,1 Milliarden Euro führen würde.

Wir haben 3 aussichtsreiche Biotechnologieaktien mit Schwerpunkt Erforschung und Entwicklung von Wirkstoffen gegen Tumorerkrankungen ausfindig gemacht, die in den kommenden Monaten und Jahren erhebliches Aufwärtspotenzial versprechen und Vervielfachungspotenzial besitzen.

Fordern Sie jetzt unseren neuen kostenlosen Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien durchstarten und zu Ihrem Börsenerfolg in 2025 beitragen könnten!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.